Allegro Diagnostics

Development of genomic tests to support the diagnosis and management of lung cancer.

Launch date

2006

Employees

Market cap

Enterprise valuation

Maynard Iowa (HQ)

Date	Investors	Amount	Round
Mar 2008*	Kodiak Venture Partners Boston University Catalyst Health Ventures	$4.0m	Series A
Oct 2009*	National Cancer Institute (NCI)	$2.8m	Grant
Jul 2011	Catalyst Health Ventures Kodiak Venture Partners & 1 more	$5.4m	Series A
Sep 2014	Veracyte	N/A	Acquisition
Total Funding		$12.2m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Allegro Diagnostics